- Home
- Industry Reports
- Biotechnology
- Healthcare
- Asia-Pacific Cell Based Assay Market – Share, Outlook, Trends, Size and Forecast (2023 – 2030)
Cell-based assays consists a variety of assays that measure cellular parameters such as proliferation, cell toxicity, production of markers, motility, activation of specific signalling pathways and changes in morphology. The cell-based assay market is driven by the increased adoption of high throughput screening methods, increasing investments in drug discovery, increase in the cell-based research activities, rapid technological advances, non-invasive methods of monitoring and the development in the automation.
Asia Pacific Cell-Based Assay Market Segments Size & Growth:
Asia Pacific Cell-Based Assay Market is expected to increase by an $ XX billion by 2024 at a CAGR of XX%. Increasing research activities in drug discovery, the rise in demand for biological drugs, technological advancement, government expenditure, rising need for toxicity screening in drugs are expected to fuel the market for cell-based assays. However, need to reduce the cost associated the drugs and technical advancements in innovations are expected to drive the market growth. Cell-based assay market is restrained by the lack of skilled personnel and high on maintenance and operational costs.
Asia Pacific Cell-Based Assay Market Segments Share:
Asia Pacific Cell-Based Assay market is segmented into the type of products which includes cell lines, ligands & Inhibitors and cell culture kits, reagents & consumers. Among these cell lines holds the largest share due to the presence of different varieties of cell lines. Based on the technology, Asia Pacific cell-based assay market flow cytometry, high content screening, label-free detection and others. Application segment includes drug discovery and ADME Research and others. Adoption of high throughput screening methods and increase in the ADME research investments expected to fuel the market growth.
Based on end-user Asia Pacific cell-based assay approach is further subdivided into biotechnology, pharmaceuticals, academia and CRO. Based on geography, Asia Pacific is anticipated to experience the rapid growth regarding the use of cell-based assay and development. Increase in awareness about the assays for drug discovery, the rise in cell-based assay applications and others are the factors for the growth in this region.
Asia Pacific Cell-Based Assay Market Trends:
- NanoBRET target engagement intracellular kinase assay was launched by the Promega to demonstrate the potency and selectivity of kinase inhibitors in living cells.
- Mammography system was launched by the GE healthcare that allows patients to control their compression by remote control.
- Volar Glass new packaging line getting manufactured by the Corning by Governor Cuomo.
Asia Pacific Cell-Based Assay Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Ametek, Inc
- Promega Corporation
- GE Healthcare
- Corning, Inc
- Bio-Rad Laboratories
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing availability of funds for research
4.1.2 Growth in adoption of high throughput screening methods
4.1.3 Advancements in drug discovery activity
4.1.4 Rising incidence of chronic diseases
4.2 Restraints
4.2.1 High investments and maintenance costs
4.2.2 Lack of skilled people to handle technology
4.3 Opportunities
4.3.1 Asian countries
4.3.2 Augmenting adoption of label-free-cell-based-array
4.4 Challenges
4.4.1 Maintenance of cell line
4.4.2 Lack of awareness about the utility of instruments for the end-user.
Chapter 5 Asia Pacific Cell-Based Assay Market – By Type of product
5.1 Assay Ready Kites
5.2 Cell Lines
5.2.1 Stem cell lines
5.2.2 Primary cell lines
5.2.3 Immortalized cell lines
5.2.4 Others
5.3 Ligands & Inhibitors
5.4 Cell culture kits, reagents & consumers
5.5 Others
Chapter 6 Asia Pacific Cell-Based Assay Market – By Technology
6.1 Flow cytometry
6.2 High content screening
6.3 Automated handling
6.4 High Throughput Screening
6.5 label-free detection
6.6 Others
Chapter 7 Asia Pacific Cell-Based Assay Market – By Application
7.1 ADME research
7.2 Drug discovery
7.3 Others
Chapter 8 Asia Pacific Cell-Based Assay Market – By End-User
8.1 Biotechnology
8.2 Pharmaceuticals
8.3 Academia
8.4 CRO
8.5 Others
Chapter 9 Asia Pacific Cell-Based Assay Market – By Country
9.1 Introduction
9.2 APAC
9.2.1 China
9.2.2 India
9.2.3 Japan
9.2.4 South Korea
9.2.5 Australia & New Zealand
9.2.6 Rest Of APAC
Chapter 10 Asia Pacific Cell-Based Assay System Market – Company Profiles
10.1 Ametek, Inc
10.2 Promega Corporation
10.3 GE Healthcare
10.4 Corning, Inc
10.5 Pall Corporation
10.6 Danaher Corporation
10.7 Cisbio Bioassays
10.8 PerkinElmer, Inc
10.9 Danaher Corporation
10.10Thermo Fisher Scientific Inc.
10.11 Cell Signaling Technology
10.12 Discoverx Corporation
Chapter 11 Asia Pacific Cell-Based Assay Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,997.97 - €6,659.88
- INR: ₹180,089.58 - ₹600,298.58
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,708.46 - £5,694.87
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Cell-based assays consists a variety of assays that measure cellular parameters such as proliferation, cell toxicity, production of markers, motility, activation of specific signalling pathways and changes in morphology. The cell-based assay market is driven by the increased adoption of high throughput screening methods, increasing investments in drug discovery, increase in the cell-based research activities, rapid technological advances, non-invasive methods of monitoring and the development in the automation.
Asia Pacific Cell-Based Assay Market Segments Size & Growth:
Asia Pacific Cell-Based Assay Market is expected to increase by an $ XX billion by 2024 at a CAGR of XX%. Increasing research activities in drug discovery, the rise in demand for biological drugs, technological advancement, government expenditure, rising need for toxicity screening in drugs are expected to fuel the market for cell-based assays. However, need to reduce the cost associated the drugs and technical advancements in innovations are expected to drive the market growth. Cell-based assay market is restrained by the lack of skilled personnel and high on maintenance and operational costs.
Asia Pacific Cell-Based Assay Market Segments Share:
Asia Pacific Cell-Based Assay market is segmented into the type of products which includes cell lines, ligands & Inhibitors and cell culture kits, reagents & consumers. Among these cell lines holds the largest share due to the presence of different varieties of cell lines. Based on the technology, Asia Pacific cell-based assay market flow cytometry, high content screening, label-free detection and others. Application segment includes drug discovery and ADME Research and others. Adoption of high throughput screening methods and increase in the ADME research investments expected to fuel the market growth.
Based on end-user Asia Pacific cell-based assay approach is further subdivided into biotechnology, pharmaceuticals, academia and CRO. Based on geography, Asia Pacific is anticipated to experience the rapid growth regarding the use of cell-based assay and development. Increase in awareness about the assays for drug discovery, the rise in cell-based assay applications and others are the factors for the growth in this region.
Asia Pacific Cell-Based Assay Market Trends:
- NanoBRET target engagement intracellular kinase assay was launched by the Promega to demonstrate the potency and selectivity of kinase inhibitors in living cells.
- Mammography system was launched by the GE healthcare that allows patients to control their compression by remote control.
- Volar Glass new packaging line getting manufactured by the Corning by Governor Cuomo.
Asia Pacific Cell-Based Assay Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Ametek, Inc
- Promega Corporation
- GE Healthcare
- Corning, Inc
- Bio-Rad Laboratories
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing availability of funds for research
4.1.2 Growth in adoption of high throughput screening methods
4.1.3 Advancements in drug discovery activity
4.1.4 Rising incidence of chronic diseases
4.2 Restraints
4.2.1 High investments and maintenance costs
4.2.2 Lack of skilled people to handle technology
4.3 Opportunities
4.3.1 Asian countries
4.3.2 Augmenting adoption of label-free-cell-based-array
4.4 Challenges
4.4.1 Maintenance of cell line
4.4.2 Lack of awareness about the utility of instruments for the end-user.
Chapter 5 Asia Pacific Cell-Based Assay Market – By Type of product
5.1 Assay Ready Kites
5.2 Cell Lines
5.2.1 Stem cell lines
5.2.2 Primary cell lines
5.2.3 Immortalized cell lines
5.2.4 Others
5.3 Ligands & Inhibitors
5.4 Cell culture kits, reagents & consumers
5.5 Others
Chapter 6 Asia Pacific Cell-Based Assay Market – By Technology
6.1 Flow cytometry
6.2 High content screening
6.3 Automated handling
6.4 High Throughput Screening
6.5 label-free detection
6.6 Others
Chapter 7 Asia Pacific Cell-Based Assay Market – By Application
7.1 ADME research
7.2 Drug discovery
7.3 Others
Chapter 8 Asia Pacific Cell-Based Assay Market – By End-User
8.1 Biotechnology
8.2 Pharmaceuticals
8.3 Academia
8.4 CRO
8.5 Others
Chapter 9 Asia Pacific Cell-Based Assay Market – By Country
9.1 Introduction
9.2 APAC
9.2.1 China
9.2.2 India
9.2.3 Japan
9.2.4 South Korea
9.2.5 Australia & New Zealand
9.2.6 Rest Of APAC
Chapter 10 Asia Pacific Cell-Based Assay System Market – Company Profiles
10.1 Ametek, Inc
10.2 Promega Corporation
10.3 GE Healthcare
10.4 Corning, Inc
10.5 Pall Corporation
10.6 Danaher Corporation
10.7 Cisbio Bioassays
10.8 PerkinElmer, Inc
10.9 Danaher Corporation
10.10Thermo Fisher Scientific Inc.
10.11 Cell Signaling Technology
10.12 Discoverx Corporation
Chapter 11 Asia Pacific Cell-Based Assay Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.